204 related articles for article (PubMed ID: 8245337)
1. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.
Morillo CA; Leitch JW; Yee R; Klein GJ
J Am Coll Cardiol; 1993 Dec; 22(7):1843-8. PubMed ID: 8245337
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia.
Milstein S; Buetikofer J; Dunnigan A; Benditt DG; Gornick C; Reyes WJ
Am J Cardiol; 1990 Jun; 65(20):1339-44. PubMed ID: 2343821
[TBL] [Abstract][Full Text] [Related]
3. Low dose disopyramide often fails to prevent neurogenic syncope during head-up tilt testing.
Kelly PA; Mann DE; Adler SW; Fuenzalida CE; Reiter MJ
Pacing Clin Electrophysiol; 1994 Apr; 17(4 Pt 1):573-6. PubMed ID: 7516539
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Sra JS; Jazayeri MR; Avitall B; Dhala A; Deshpande S; Blanck Z; Akhtar M
N Engl J Med; 1993 Apr; 328(15):1085-90. PubMed ID: 8455666
[TBL] [Abstract][Full Text] [Related]
5. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo.
Moya A; Permanyer-Miralda G; Sagrista-Sauleda J; Carne X; Rius T; Mont L; Soler-Soler J
J Am Coll Cardiol; 1995 Jan; 25(1):65-9. PubMed ID: 7798528
[TBL] [Abstract][Full Text] [Related]
6. Is home orthostatic self-training effective in preventing neurally mediated syncope?
On YK; Park J; Huh J; Kim JS
Pacing Clin Electrophysiol; 2007 May; 30(5):638-43. PubMed ID: 17461874
[TBL] [Abstract][Full Text] [Related]
7. Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.
Schroeder C; Birkenfeld AL; Mayer AF; Tank J; Diedrich A; Luft FC; Jordan J
J Am Coll Cardiol; 2006 Aug; 48(3):516-22. PubMed ID: 16875978
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of pharmacological therapy for vasovagal syncope on the basis of reproducibility during head-up tilt testing.
Nakagawa H; Kobayashi Y; Kikushima S; Shinohara M; Obara C; Zinbo Y; Chiyoda K; Miyata A; Tanno K; Baba T; Katagiri T
Jpn Circ J; 1998 Oct; 62(10):727-32. PubMed ID: 9805252
[TBL] [Abstract][Full Text] [Related]
9. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
Cox MM; Perlman BA; Mayor MR; Silberstein TA; Levin E; Pringle L; Castellanos A; Myerburg RJ
J Am Coll Cardiol; 1995 Nov; 26(5):1293-8. PubMed ID: 7594046
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of clonazepam in refractory neurally mediated syncope.
Kadri NN; Hee TT; Rovang KS; Mohiuddin SM; Ryan T; Ashraf R; Huebert V; Hilleman DE
Pacing Clin Electrophysiol; 1999 Feb; 22(2):307-14. PubMed ID: 10087545
[TBL] [Abstract][Full Text] [Related]
11. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.
Kaufmann H; Saadia D; Voustianiouk A
Ann Neurol; 2002 Sep; 52(3):342-5. PubMed ID: 12205647
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study.
Foglia-Manzillo G; Giada F; Gaggioli G; Bartoletti A; Lolli G; Dinelli M; Del Rosso A; Santarone M; Raviele A; Brignole M
Europace; 2004 May; 6(3):199-204. PubMed ID: 15121070
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of different treatment strategies for neurocardiogenic syncope.
Natale A; Sra J; Dhala A; Wase A; Jazayeri M; Deshpande S; Blanck Z; Akhtar M
Pacing Clin Electrophysiol; 1995 Apr; 18(4 Pt 1):655-62. PubMed ID: 7596849
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of intravenous metoprolol to prevent syncope induced by head-up tilt.
Kluger J; Bazunga M; Goldman R; O'Rangers E; Azar P; Chow MS
Am J Cardiol; 1998 Sep; 82(6):820-3, A10. PubMed ID: 9761101
[TBL] [Abstract][Full Text] [Related]
15. Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management.
Grubb BP; Wolfe D; Samoil D; Madu E; Temesy-Armos P; Hahn H; Elliott L
J Am Geriatr Soc; 1992 Nov; 40(11):1123-8. PubMed ID: 1401697
[TBL] [Abstract][Full Text] [Related]
16. Absence of tachycardia during tilt test predicts failure of beta-blocker therapy in patients with neurocardiogenic syncope.
Leor J; Rotstein Z; Vered Z; Kaplinsky E; Truman S; Eldar M
Am Heart J; 1994 Jun; 127(6):1539-43. PubMed ID: 7910998
[TBL] [Abstract][Full Text] [Related]
17. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing.
Sra JS; Anderson AJ; Sheikh SH; Avitall B; Tchou PJ; Troup PJ; Gilbert CJ; Akhtar M; Jazayeri MR
Ann Intern Med; 1991 Jun; 114(12):1013-9. PubMed ID: 2029096
[TBL] [Abstract][Full Text] [Related]
18. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study.
Madrid AH; Ortega J; Rebollo JG; Manzano JG; Segovia JG; Sánchez A; Peña G; Moro C
J Am Coll Cardiol; 2001 Feb; 37(2):554-9. PubMed ID: 11216978
[TBL] [Abstract][Full Text] [Related]
19. Syncope recurrence can better be predicted by history than by head-up tilt testing in untreated patients with suspected neurally mediated syncope.
Grimm W; Degenhardt M; Hoffman J; Menz V; Wirths A; Maisch B
Eur Heart J; 1997 Sep; 18(9):1465-9. PubMed ID: 9458453
[TBL] [Abstract][Full Text] [Related]
20. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope.
Natale A; Akhtar M; Jazayeri M; Dhala A; Blanck Z; Deshpande S; Krebs A; Sra JS
Circulation; 1995 Jul; 92(1):54-8. PubMed ID: 7788917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
